Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Quest Diagnostics Incorporated

Quest Diagnostics Incorporated (DGX) Stock Overview

Explore Quest Diagnostics Incorporated’s financial performance, market position, analyst ratings, and future outlook.

DGX●NYSE
HealthcareMedical - Diagnostics & Research
$208.01
$2.01(0.98%)
U.S. Market is Open · 15:36

Quest Diagnostics Incorporated (DGX)

Meyka AI Score

Z

Key Financials

Market Cap22.3B
P/E Ratio22.05
EPS (TTM)$10.14
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$208.43
3 Months$209.37
1 Year Target$195.87

DGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Quest Diagnostics Incorporated (DGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.13, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $195.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.05 and a market capitalization of 22.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.01%
5-Day Change
-3.07%
1-Month Change
-0.16%
3-Month Change
5.45%
6-Month Change
6.09%
Year-to-Date (YTD) Change
16.32%
1-Year Change
21.29%
3-Year Change
44.27%
5-Year Change
50.56%
All-Time (Max) Change
5667.14%

Contact Information

https://www.questdiagnostics.com
973 520 2700
500 Plaza Drive, Secaucus, NJ, 07094

Company Facts

550,000 Employees
IPO DateDec 17, 1996
CountryUS
Actively Trading

Frequently Asked Questions